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Abstract:  Polymeric 3-alkylpyridinium salts (poly-APS) present in the marine sponge 
Reniera sarai show a broad spectrum of biological activities. They are lytic to erythrocytes 
and various other mammalian cells, enabling the transfection of the latter with alien DNA. 
Furthermore, they show inhibitory effects to marine bacteria and can inhibit fouling of 
micro- and macroorganisms to submerged surfaces. Finally, poly-APS act as potent 
cholinesterase inhibitors.  The kinetics of acetylcholinesterase inhibition by poly-APS in 
vitro is complex and comprises several successive phases ending in irreversible inhibition 
of the enzyme. The latter is accounted for by aggregation and precipitation of the enzyme-
inhibitor complexes. Poly-APS are lethal to rats in concentrations above 2.7  mg/kg. 
Monitoring of the basic vital functions and histopathological analysis showed that the 
effects directly ascribable to acetylcholinesterase inhibition are only observed after 
application of lower concentrations of poly-APS. At higher concentrations, such effects 
were masked by other, more pronounced and faster developing lethal effects of the toxin, 
such as haemolysis and platelet aggregation. 
 
Keywords:  Acetylcholinesterase inhibitor, marine sponge, polymeric alkylpyridinium 
salts, Reniera sarai, toxicity. 
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1.  Introduction 
 
Monomeric, oligomeric and polymeric 3-alkylpyridiniums and 3-alkylpyridines comprise a group 
of biologically active compounds found in several sponges of the order Haplosclerida [1-4]. In general, 
the variety and potency of the biological effects of these compounds increase with their degree of 
polymerisation, resulting in complex and unprecedented mechanisms of action and/or toxicity. 
3-Alkylpyridinium polymers isolated so far from haplosclerid marine sponges are shown in Figure 1. 
Among them, polymeric 3-alkylpyridinium salts (poly-APS), isolated from crude extracts of the 
Mediterranean marine sponge Reniera sarai, show the highest degree of polymerisation.  
 
Figure 1. Chemical structures of 3-alkylpyridinium polymers isolated from haplosclerid 
marine sponges. A, halitoxins [10,12]; B, amphitoxins [13]; C, EGF-active factors [14]; 
D, poly-APS [5]. 
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Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry has 
shown that poly-APS are a mixture of two main polymers with molecular weights of 5520 and 18900 
Da, corresponding to polymers composed of 29 and 99 covalently head-to-tail linked N-butyl-3-butyl 
pyridinium units, respectively (Figure 1D). Poly-APS are highly water-soluble (up to a concentration 
of 50 mg/mL), and have only limited solubility in other less polar organic solvents like methanol and 
ethanol. At concentrations of more than 0.23 mg/mL they form large supramolecular aggregates with 
an average hydrodynamic radius of 23±2 nm [5]. This behaviour resembles that of other structurally Mar. Drugs 2007, 5                                                  
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related cationic detergents like cetylpyridinium chloride (CPC) and cetyltrimethylammonium bromide 
(CTAB) [6]. Similarly, the biological effects exerted by poly-APS reflect, at least in part, their 
surfactant-like nature. At concentrations below 0.5 μg/mL, poly-APS act as antifouling compounds 
[7], are strong inhibitors of acetylcholinesterase (AChE) [5], and show moderate haemolytic and 
cytotoxic activity [6,8] that allows stable transfection of living cells with double-stranded DNA [9]. 
The concentrations of poly-APS that produce biological effects are far below their aggregation point, 
strongly suggesting that the observed activities are properties of the monomolecular form of the 
compounds. In higher concentrations (above 1 mg/mL), poly-APS can be toxic and lethal to 
experimental animals after intravenous (i.v.) application. The aim of this review is to summarize 
current knowledge on the biological activity and toxicity of poly-APS, with particular emphasis on 
mechanisms of poly-APS toxicity in vivo, and to correlate their structural characteristics and behaviour 
in aqueous solution with their observed biological effects.  
 
2.  Biological activity and toxicity of 3-alkylpyridinium compounds – an overview 
 
To date, around 30 and 50 structurally different 3-alkylpyridinium and 3-alkylpyridine compounds 
have been isolated, respectively, from marine sponges. They occur mainly in sponges belonging to the 
order Haplosclerida, and can therefore also be used as chemical markers for the determination of 
haplosclerid sponges. 3-Alkylpyridinium and 3-alkylpyridine compounds and their biological activities 
have been described in detail in several reviews [1-4]. The majority of these compounds are 
monomeric and display mainly cytotoxic and/or antibacterial activities at concentrations of a few 
micrograms per mL [3,4]. A smaller number of oligomeric and polymeric 3-alkylpyridinium salts have 
also been isolated and partially characterized. Linear and cyclic 3-alkylpyridinium dimers and trimers 
are reported to be cytotoxic, antimitotic and inhibitory to muscarinic acetylcholine receptors and to 
some enzymes like histone deacetylase [reviewed in 3,4]. Polymeric compounds on the other hand, 
like halitoxins [10-12], amphitoxins [13], natural and synthetic epidermal growth factor (EGF)-active 
factors [14,15] and poly-APS [5] (Figure 1), show many more diverse and potent biological activities. 
Halitoxin was reported to be haemolytic and cytotoxic towards transformed cells, toxic to fish and 
mice, inhibitory to some Gram positive bacteria, antimitotic and neurotoxic [10,11], and amphitoxin 
shows antifeedant activity against fish [13]. A mixture of these two toxins, isolated from the 
haplosclerid sponge Amphimedon viridis, was found to selectively inhibit the growth of marine and 
sponge-associated bacteria [16]. EGF-active factors are cytotoxic and inhibitory to the EGF receptor 
that is overexpressed in several tumour cells [14]. Finally, poly-APS possess a broad range of potent 
biological activities, the most prominent being cytolytic, haemolytic, acetylcholinesterase-inhibitory 
and antifouling, that are reviewed in detail in the following sections.  
In general, several biological activities of 3-alkylpyridinium compounds, as well as their potency, 
increase with the degree of polymerisation. This phenomenon is most prominent in one of the most 
studied 3-alkylpyridinium polymers, poly-APS, whose polycationic nature and surfactant-like 
behaviour in aqueous solution are responsible not only for the high potency of the biological activities, 
but also for the complex and unprecedented mechanisms by which the latter are achieved.  
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3.  Biological activities of polymeric 3-alkylpyridinium salts (poly-APS) from the marine sponge 
Reniera sarai 
 
3.1. Membrane activity  
 
The ability of poly-APS to form lesions in biological membranes can be explained, at least 
partially, by their surfactant-like characteristics. Despite their polymeric nature and considerably 
shorter alkyl tail, poly-APS are structurally related to cationic pyridinium detergents like CPC and 
CTAB [6]. In aqueous solution poly-APS display surfactant-like properties; for example, at 0.23 
mg/mL, they form large micelle-like non-covalently bound aggregates [5]. Poly-APS are lytic to 
erythrocytes and different cell lines in sub-micromolar concentrations [8]. In erythrocytes, they induce 
the formation of discrete lesions in the membrane (5.8 nm in diameter) by a colloid-osmotic type of 
lysis [6]. Haemolysis can be attenuated or prevented by various divalent cations [6], and is surprisingly 
much more effective at lower temperatures (Sepčić and Turk, unpublished observation). Further 
electrophysiological studies on different cell lines showed that poly-APS display dose-dependent 
interactions with cell membranes [17]. At low concentrations (around 0.5 μg/mL), these can be 
reversible and can enable transfection of HEK293 cells with alien DNA for enhanced green fluorescent 
protein, pBABE and TNF receptor type 2 [9,18]. Although being four-fold less efficient than the 
transfection agent lipofectamine, compounds like poly-APS have been proposed as new tools for stable 
cell transfection [19]. The mechanism of poly-APS-induced transfection differs from that induced by 
lipofectamine [18] and still remains to be explained. It comprises both the formation of reversible 
membrane lesions and binding to DNA [18], and is (like haemolysis) more effective at lower 
temperatures (7-12°C), suggesting that temperature-dependent alterations of the physical properties of 
the membrane can be key events in poly-APS membrane activity. Furthermore, the degree of 
polymerisation appears to play an important role in this event, since monomeric CPC and CTAB failed 
to transfect cells [17]. Recent studies, using surface plasmon resonance [20], suggest that the 
mechanism of poly-APS-induced membrane activity comprises sequential binding of these molecules 
to lipid membranes. Poly-APS molecules that are present within the membrane at sub-lytic 
concentrations might provide either cooperative support for further poly-APS – membrane 
interactions, or could produce sites of membrane vulnerability, leading to its disruption.  
 
3.2. Antifouling activity 
 
Sponges are sessile animals that breathe and that feed by filtering the water. Production of 
biologically active compounds that prevent other micro- and macroorganisms from settling on their 
surface is therefore extremely important for their survival. Indeed, we found that the surface of 
Reniera sarai is almost never fouled by other marine organisms. It is veiled by a greasy coating 
incorporating large amounts of poly-APS, which appear to be responsible for the observed effective 
antisettlement activity. The antimicro- and antimacrofouling activity of poly-APS was studied in 
details under in vitro conditions, and compared to booster biocides like Zinc Omadine
® and Copper 
Omadine
®, compounds showing irreversible antifouling properties that are due to their toxicity 
towards marine biota [7]. Mar. Drugs 2007, 5                                                  
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Poly-APS inhibit the settlement of Balanus amphitrite cypris larvae with an EC50 of 0.27 μg/mL – 
about ten fold less effective than the booster biocides. However, in contrast to the latter, the 
antisettlement activity of poly-APS was almost non-toxic and reversible. A similar phenomenon was 
also observed in the swimming inhibition assay against B. amphitrite nauplii, as well as in toxicity 
tests against other relevant representatives of the phyto- and zooplankton (e.g. microalga Tetraselmis 
suecica and larvae of the edible mussel Mytilus galloprovincialis). Besides their antimacrofouling 
properties, poly-APS, in the range of 0.1–1 μg/mL, also inhibit fouling by bacteria, fungi, and 
microalgae [21], and show considerable antibacterial activity against marine biofilm bacteria [22]. All 
these features suggest poly-APS (or their synthetic analogues) as good candidates for new biocides in 
the development of antifouling paints. The poly-APS inhibition of settlement of cyprids can be 
partially explained in terms of their surfactant properties. In aqueous solution, they behave similarly to 
cationic detergents [6] and are lytic to different cell lines [8], so the detergent-induced prevention of 
adhesion and lysis of microorganisms could be possible mechanisms of their antifouling action. On the 
other hand, acetylcholine was suggested to be involved in the settlement of B. amphitrite cyprids [23], 
and AChE activity has been detected in the setae of the antennules, which play an important role in the 
process of settlement of this organism [24]. The application of AChE inhibitors clearly inhibited larval 
settlement [23], so another mechanism of poly-APS - induced antifouling activity could derive from 
their potent AChE-inhibitory properties [25,26]. 
 
3.3.  Inhibition of acetylcholinesterase 
 
The most prominent biological activity attributed to poly-APS is probably the inhibition of 
acetylcholinesterase (AChE), the enzyme that hydrolyses the neurotransmitter acetylcholine (ACh) in 
nervous system synapses. The hydrolysis of ACh takes place at the bottom of a 20 Å deep enzyme 
active gorge, which bears the anionic site responsible for the recognition of choline, and the catalytic 
site with the active serine (responsible for cleaving the substrate). At the rim of the gorge is another 
choline binding site – the peripheral anionic site [27]. This site is responsible for the inhibition by 
excess substrate, and for binding of the AChE inhibitor propidium. Only a few natural AChE inhibitors 
have been isolated from marine organisms [5, 28-31] and, of these, poly-APS are the most potent, with 
unprecedented inhibition kinetics. Simple synthetic mono-, di- and tetrameric alkylpyridinium 
compounds have also been described as anti-cholinesterase agents that act in micromolar 
concentrations [25, 32, 33]. All these compounds show reversible and competitive, non-competitive or 
mixed type inhibition kinetics following their binding to the anionic site inside the active gorge, to the 
peripheral anionic site, or to both, respectively. In contrast, poly-APS strongly inhibits AChEs and 
butyrylcholinesterases (BuChEs) from different sources at nanomolar concentrations [5, 25], showing 
a non-linear, time-dependent course of inhibition. These types of inhibition curves often reflect the 
presence of a slow-binding and/or irreversible component in the inhibition, the latter being confirmed 
by the fact that the activity of the enzyme could never be completely restored after dilution of the 
enzyme-inhibitor mixture [25]. By analysing the different phases of AChE inhibition by poly-APS, we 
found that the first interaction between the two molecules is reversible and non-competitive, with a Ki 
of 11±3 nM. This finding, together with the ability of poly-APS to compete with the binding of 
propidium or with substrate inhibition (at high concentrations of substrate), suggests that the first Mar. Drugs 2007, 5                                                  
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binding of the inhibitor occurs at the peripheral anionic site of AChE [25]. This binding is followed by 
a slow-binding component showing a Ki (krec/kbind) of 3.23 μM, and finally by irreversible inactivation 
of the enzyme, following pseudo-first order kinetics and showing a ki of 388±47 mmol
-1Lmin
-1 [25]. 
The observed complex inhibition kinetics result from the high degree of polymerisation of poly-APS. 
Indeed, the inhibitor does not induce significant changes of the enzyme conformation, but extensively 
quenches its intrinsic tryptophan fluorescence, suggesting that the first, reversible binding to the 
peripheral anionic site is followed by successive binding of different poly-APS pyridinium units to 
several sites on the AChE molecule [26]. This multisite binding between the two molecules results in 
aggregation and precipitation of the enzyme-inhibitor complexes, that can be followed by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the sediment obtained 
after AChE – poly-APS incubation and centrifuging, as well as by eye [26]. It is interesting that poly-
APS appear to interact specifically with AChE, since they do not inhibit other enzymes like trypsin 
and alkaline phosphatase [26], and are only slightly inhibitory to human protein phosphatase 2A [33]. 
It must however be stressed that the polycationic nature of poly-APS can result in binding to other 
proteins that is less specific, as demonstrated for serum proteins [34]. 
The AChE-inhibitory activity appears to be related to the antitumoral activity of poly-APS towards 
non-small cell lung cancer cells (NSCLC). These cells are responsible for the most common form of 
lung cancer, and have been shown to express molecules belonging to the cholinergic system, such as 
cholinoacetyltransferase, vesicular ACh transporter and AChE. Poly-APS, in non-toxic concentrations, 
show a significant selective cytotoxicity towards NSCLC cells, with no significant effects on normal 
cells in vitro and normal tissues in vivo [35]. Based on observations that some drugs used in lung 
cancer treatment and therapy, such as Irinotecan, can also inhibit AChE activity [36,37], our results 
suggest that the selective cytotoxicity of poly-APS against NSCLC cells derives from the interruption 
of the NSCLC cells’ cholinergic system through AChE inhibition, resulting in their apoptosis. 
 
4.  Toxicity of 3-alkylpyridinium compounds – an overview 
 
The toxic effects of 3-alkylpyridinium compounds, commonly expressed as an EC50 or LD50 dose, 
have been quantified using different plant and animal species. These effects include toxicity and/or 
antifeeding activity against different marine organisms (fish, starfish and amphipods), which were 
observed for a mixture of polymeric halitoxins [10], amphitoxins [13], and for oligomeric haliclamines 
[38]. A recent report on the activity of cyclohaliclonamines A-E from an unidentified sponge of the 
genus Haliclona [39] demonstrated the toxicity of these compounds in a brine shrimp assay, with an 
LD50 of 65 μg/mL. The toxic effects of polymeric alkylpyridinium salts (poly-APS) from the marine 
sponge Reniera sarai were also studied on various target organisms, and are discussed in detail below. 
 
5.  Toxicity of polymeric 3-alkylpyridinium salts (poly-APS) from the marine sponge R. sarai 
 
5. 1. Toxicity of poly-APS to non-mammals 
 
During the evaluation of their antifouling potential, polymeric 3-alkylpyridinium salts (poly-APS) 
from the sponge Reniera sarai were found to be slightly toxic to the naupliar larvae of Balanus Mar. Drugs 2007, 5                                                  
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amphitrite (LC50 = 30.01 μg/mL in a 24-h assay), to the microalga Tetraselmis suecica (LC50 = 10.66 
μg/mL in a 72-h assay), and to trocophora and veliger larvae of the edible mussel Mytillus 
galloprovincialis (LC50 = 2.42 and 2.73 μg/mL in a 24 h assay, respectively) [7]. Interestingly, in 
contrast to amphitoxins [13], poly-APS were not ichtyotoxic towards freshwater and sea fish at a 
concentration of 0.1 μg/mL (unpublished observation).  
 
5. 2. Toxicity of poly-APS to mammals 
 
The ability of poly-APS to strongly inhibit AChE in vitro has resulted in further studies of their 
effects in experimental rodents in vivo [34, 40, 41]. In sublethal doses, poly-APS produce 
pharmacological effects characteristic of AChE inhibition, including bradicardia, low blood pressure 
and prolonged expiratory phase of breathing. However, the lethality, following the injection of rats 
with a lethal dose of poly-APS, appears not to derive just from AChE inhibition, but also seems to 
reflect their highly polycationic nature and surfactant-like behaviour. 
In vivo experiments with poly-APS were performed on male Wistar rats. Different doses of the 
toxin (dissolved in physiological solution) were applied slowly for 20–40 s through the cannulated 
jugular vein. Electrocardiograms (ECG), blood pressure and breathing patterns were monitored, 
followed by histological post-mortem analysis of vital organs. At sublethal doses (below 1 mg/kg) 
poly-APS induced a transient fall in blood pressure, bradycardia and prolongation of expirium [40,41]. 
These signs probably derive from the inhibition of AChE. The consequent accumulation of ACh and 
its peripheral action could readily result in the observed effects like bradycardia and fall in cardiac 
output. However, at lethal doses (above 2.7 mg/kg), the signs were not completely typical of AChE 
inhibition, and were masked by other, more pronounced and faster developing lethal effects produced 
by the toxin. Reduction of the arterial blood pressure to a mid-circulatory pressure was observed, 
which could reflect a peripheral effect of ACh on the heart, and probably the central action of poly-
APS (acting as anti-AChE agents) on the medullary vasomotor and cardiac centres of the central 
nervous system. Furthermore, the observed cessation of breathing after a few breaths, with cyanosis 
and an increase of the residual volume, may also be induced by the AChE-inhibitory activity of poly-
APS, resulting in contraction of smooth muscle fibres of the bronchioles. The resulting hypoxemia can 
both intensify sympathetic tone and trigger ACh-evoked epinephrine release from the adrenal medulla. 
For these reasons, it is not surprising that normal or even increased heart rate was observed in 
experimental animals receiving lethal doses of poly-APS. These signs are similar to those induced by a 
related sponge-derived compound, halitoxin [10,11] which was lethal to mice, with an i.v. LD50 of 1.4 
mg/kg. The intoxicated mice were cyanotic and died of respiratory arrest.  
Autopsy of the experimental animals that died due to the effects of poly-APS revealed that the 
lumen of the mid- and small-sized blood vessels in the heart and lungs were filled with granular 
brownish material with inclusions of fibrin, red blood cells and platelets. Perivascular and intra-
alveolar haemorrhages were also regularly observed that could also contribute to the diffusion 
abnormalities and result in hypoxemia. Data obtained on blood samples from animals treated with 
poly-APS showed numerous thrombocyte aggregates [40,41]. Further in vitro studies have revealed 
that poly-APS do not affect the coagulation rate, but rather induce thrombocyte aggregation in a dose-
dependent manner. Aggregation of thrombocytes could be followed, up to a poly-APS concentration of Mar. Drugs 2007, 5                                                  
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100 ng/mL [34,41]. This fact, together with the finding that they can bind directly and non-specifically 
to plasma serum proteins [34], has been proposed as the underlying mechanism of poly-APS lethality.  
The different effects observed after intravenous applications of different doses of poly-APS could 
derive from their ability to form large, non-covalently bound supramolecular aggregates, a process that 
occurs in water solutions at around 0.23 mg/mL [5]. Thus, at lower doses, the greater part of the poly-
APS injected into the experimental animal probably exists in the monomolecular form, which allows 
passage through the capillary walls and action as AChE inhibitors on neuromuscular junctions. 
Therefore, higher concentrations of poly-APS in their monomolecular form might block 
neuromuscular transmission and produce respiratory arrest. At higher doses, in which the majority of 
poly-APS exist in the form of spherically shaped aggregates with a diameter of 46 nm [5], crossing of 
capillary walls is less reasonable, so that other toxic mechanisms, including the aggregation of poly-
APS with thrombocytes and serum proteins, leading to the formation of large intravascular plugs, are 
more pronounced. The ability of poly-APS to permeabilize the membranes of erythrocytes and other 
cells [6,8] is an additional factor that could produce toxic effects through direct cytolysis of endothelial 
cells. Indeed, microscope examination of blood smears obtained from poly-APS-treated experimental 
animals revealed several lysed erythrocytes which could, in the case of severe lysis, produce 
hyperkalaemia and reduce oxygen transport capacity. Blood samples of halitoxin-treated experimental 
animals also showed partial haemolysis, and lethal effects were therefore attributed to the haemolytic 
action of the toxin [11].  
In conclusion, the observed in vivo toxic effects of poly-APS (and probably of other polymerised 
3-alkylpyridinium salts like halitoxins [10,11]) reflect their polycationic nature and behaviour in 
aqueous solution. While at lower concentrations poly-APS can act as AChE inhibitors, at higher doses 
other mechanisms producing haematological and vascular effects dominate and mask these effects. 
Besides the membrane-permeabilizing activity on erythrocytes and other tissue cells, which is 
probably also responsible for arrhythmia and thrombocyte aggregation, the non-specific binding of 
poly-APS to different serum proteins and membrane-bound proteins on platelets induces the formation 
of large plugs that could block the small blood vessels and stop the lung and heart blood flow.  
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